175 related articles for article (PubMed ID: 19293668)
1. Increased circulating placental growth factor during percutaneous coronary intervention is associated with applied radiocontrast agent.
Steppich BA; Kaufmann J; Sepp D; Kunert K; Rutz T; Stratz C; Ott I
Coron Artery Dis; 2009 Mar; 20(2):130-7. PubMed ID: 19293668
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of placental growth factor in patients with acute chest pain.
Heeschen C; Dimmeler S; Fichtlscherer S; Hamm CW; Berger J; Simoons ML; Zeiher AM;
JAMA; 2004 Jan; 291(4):435-41. PubMed ID: 14747500
[TBL] [Abstract][Full Text] [Related]
3. Effect of heparin on blood vascular endothelial growth factor levels in patients with ST-elevation acute myocardial infarction undergoing primary percutaneous coronary intervention.
Pyda M; Korybalska K; Ksiazek K; Grajek S; Lanocha M; Lesiak M; Wiśniewska-Elnur J; Olasińska A; Breborowicz A; Cieśliński A; Witowski J
Am J Cardiol; 2006 Oct; 98(7):902-5. PubMed ID: 16996870
[TBL] [Abstract][Full Text] [Related]
4. Atorvastatin increases plasma soluble Fms-like tyrosine kinase-1 and decreases vascular endothelial growth factor and placental growth factor in association with improvement of ventricular function in acute myocardial infarction.
Kodama Y; Kitta Y; Nakamura T; Takano H; Umetani K; Fujioka D; Saito Y; Kawabata K; Obata JE; Mende A; Kobayashi T; Kugiyama K
J Am Coll Cardiol; 2006 Jul; 48(1):43-50. PubMed ID: 16814647
[TBL] [Abstract][Full Text] [Related]
5. Relation of various plasma growth factor levels in patients with stable angina pectoris and total occlusion of a coronary artery to the degree of coronary collaterals.
Briguori C; Testa U; Colombo A; Petrucci E; Condorelli G; Airoldi F; Peschle C; Condorelli G
Am J Cardiol; 2006 Feb; 97(4):472-6. PubMed ID: 16461039
[TBL] [Abstract][Full Text] [Related]
6. Relationship between serum vasoactive factors and plaque morphology in patients with non-ST-segment elevated acute coronary syndrome.
Lu YF; Lü SZ; Chen YD
Chin Med J (Engl); 2010 Jan; 123(2):193-7. PubMed ID: 20137369
[TBL] [Abstract][Full Text] [Related]
7. [Roles of placental growth factor in percutaneous coronary angioplasty and stent implantation].
Zhu Y; You G; Zhang L; Wei X; Liu X
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2008 May; 22(5):586-8. PubMed ID: 18630442
[TBL] [Abstract][Full Text] [Related]
8. An elevated ratio of placental growth factor to soluble fms-like tyrosine kinase-1 predicts adverse outcomes in patients with stable coronary artery disease.
Matsumoto T; Uemura S; Takeda Y; Matsui M; Okada S; Nishida T; Soeda T; Okayama S; Somekawa S; Ishigami K; Onoue K; Kawata H; Kawakami R; Horii M; Saito Y
Intern Med; 2013; 52(10):1019-27. PubMed ID: 23676585
[TBL] [Abstract][Full Text] [Related]
9. Elevated placental growth factor levels are associated with adverse outcomes at four-year follow-up in patients with acute coronary syndromes.
Lenderink T; Heeschen C; Fichtlscherer S; Dimmeler S; Hamm CW; Zeiher AM; Simoons ML; Boersma E;
J Am Coll Cardiol; 2006 Jan; 47(2):307-11. PubMed ID: 16412852
[TBL] [Abstract][Full Text] [Related]
10. [Changes of circulating endothelial progenitor cells in patients with coronary heart diseases before and after percutaneous coronary intervention].
Luo YS; Qian JY; Zhang L; Ma JY; Huang D; Fan B; Ge JB
Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Feb; 38(2):126-30. PubMed ID: 20398557
[TBL] [Abstract][Full Text] [Related]
11. [Neoangiogenesis and coronary atherosclerosis: diagnostic value of a novel biochemical marker placenta growth factor in patients with ischemic heart disease].
Shevchenko AO; Shevchenko OP; Orlova OV; Tulikov MV
Kardiologiia; 2006; 46(11):9-15. PubMed ID: 17159877
[TBL] [Abstract][Full Text] [Related]
12. Predictive value of coronary artery stenoses and C-reactive protein levels in patients with stable coronary artery disease.
Arroyo-Espliguero R; Avanzas P; Quiles J; Kaski JC
Atherosclerosis; 2009 May; 204(1):239-43. PubMed ID: 18823889
[TBL] [Abstract][Full Text] [Related]
13. Management patterns of non-ST segment elevation acute coronary syndromes in relation to prior coronary revascularization.
Elbarasi E; Goodman SG; Yan RT; Welsh RC; Kornder J; Wong GC; Déry JP; Anderson F; Gore JM; Fox KA; Yan AT; ;
Am Heart J; 2010 Jan; 159(1):40-6. PubMed ID: 20102865
[TBL] [Abstract][Full Text] [Related]
14. Serum choline levels in patients with stable angina and acute coronary syndromes: relation to the severity of coronary artery disease.
Sentürk T; Tütüncü A; Ozdemir B; Ozdabakoğlu O; Aydin S; Baran I; Güllülü S; Savci V; Aydinlar A
Coron Artery Dis; 2010 Dec; 21(8):466-71. PubMed ID: 20926949
[TBL] [Abstract][Full Text] [Related]
15. Cardiac expression of placental growth factor predicts the improvement of chronic phase left ventricular function in patients with acute myocardial infarction.
Iwama H; Uemura S; Naya N; Imagawa K; Takemoto Y; Asai O; Onoue K; Okayama S; Somekawa S; Kida Y; Takeda Y; Nakatani K; Takaoka M; Kawata H; Horii M; Nakajima T; Doi N; Saito Y
J Am Coll Cardiol; 2006 Apr; 47(8):1559-67. PubMed ID: 16630991
[TBL] [Abstract][Full Text] [Related]
16. Percutaneous coronary intervention in tortuous coronary arteries: associated complications and strategies to improve success.
Saeed B; Banerjee S; Brilakis ES
J Interv Cardiol; 2008 Dec; 21(6):504-11. PubMed ID: 18705640
[TBL] [Abstract][Full Text] [Related]
17. Quantitative results of baseline angiography and percutaneous coronary intervention in the COURAGE trial.
Mancini GB; Bates ER; Maron DJ; Hartigan P; Dada M; Gosselin G; Kostuk W; Sedlis SP; Shaw LJ; Berman DS; Berger PB; Spertus J; Mavromatis K; Knudtson M; Chaitman BR; O'Rourke RA; Weintraub WS; Teo K; Boden WE;
Circ Cardiovasc Qual Outcomes; 2009 Jul; 2(4):320-7. PubMed ID: 20031857
[TBL] [Abstract][Full Text] [Related]
18. Relation of leukocytosis to C-reactive protein and interleukin-6 among patients undergoing percutaneous coronary intervention.
Gogo PB; Schneider DJ; Terrien EF; Watkins MW; Sobel BE; Dauerman HL
Am J Cardiol; 2005 Aug; 96(4):538-42. PubMed ID: 16098308
[TBL] [Abstract][Full Text] [Related]
19. Prevalence, predictors, and impact of conservative medical management for patients with non-ST-segment elevation acute coronary syndromes who have angiographically documented significant coronary disease.
Chan MY; Mahaffey KW; Sun LJ; Pieper KS; White HD; Aylward PE; Ferguson JJ; Califf RM; Roe MT
JACC Cardiovasc Interv; 2008 Aug; 1(4):369-78. PubMed ID: 19463332
[TBL] [Abstract][Full Text] [Related]
20. Inflammatory markers, angiographic severity of coronary artery disease, and patient outcome.
Sukhija R; Fahdi I; Garza L; Fink L; Scott M; Aude W; Pacheco R; Bursac Z; Grant A; Mehta JL
Am J Cardiol; 2007 Apr; 99(7):879-84. PubMed ID: 17398176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
